Onyx Pharmaceuticals (ONXX)
Add to Watchlists Create an AlertOnyx Pharmaceuticals Retained Earnings:
-651.07M for Dec. 31, 2012Onyx Pharmaceuticals Historical Retained Earnings Data
Pro Data ExportThere is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | -651.07M |
| Sept. 30, 2012 | -608.15M |
| June 30, 2012 | -625.55M |
| March 31, 2012 | -519.50M |
| Dec. 31, 2011 | -463.29M |
| Sept. 30, 2011 | -679.96M |
| June 30, 2011 | -643.10M |
| March 31, 2011 | -588.56M |
| Dec. 31, 2010 | -539.40M |
| Sept. 30, 2010 | -522.28M |
| June 30, 2010 | -563.78M |
| March 31, 2010 | -466.59M |
| Dec. 31, 2009 | -454.55M |
| Sept. 30, 2009 | -449.04M |
| June 30, 2009 | -457.27M |
| March 31, 2009 | -466.64M |
| Dec. 31, 2008 | -470.71M |
| Sept. 30, 2008 | -440.52M |
| June 30, 2008 | -452.77M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
| Sept. 30, 2000 | Go Pro |
About Retained Earnings
The net income that remains after paying dividends. It is reported on the balance sheet as the cumulative sum of each year's retained earnings over the life of the business. Retained earnings can be used to pay debt and future dividends, or can be reinvested into business activities.
The "retained" refers to the earnings after paying out dividends. Companies with increasing retained earnings is good, because it means the company is staying consistently profitable. If a company has a yearly loss, this number is subtracted from retained earnings.
If a company's annual net income was 5 million, paid out 3 million in dividends, and had a retained earnings of 9 million, retained earnings at the end of 2012 would be 11 million (5-3+9). Similarly if next year the company paid no dividends but had a yearly net income loss of 5 million, retained earnings would be 6 million (11-5).
Learn More
ONXX Retained Earnings Benchmarks
| Companies | |
|---|---|
| WuXi PharmaTech | 188.60M |
| AVEO Pharmaceuticals | -320.26M |
| Celgene Corporation | 3.408B |
ONXX Retained Earnings Rankings
| Overall |
38th percentile 4937 of 8005 |
| Sector |
13th percentile 594 of 686 in Healthcare |
| Industry |
17th percentile 204 of 248 in Biotechnology |
ONXX Retained Earnings Range, Past 5 Years
| Minimum | -679.96M | Sep 2011 |
| Maximum | -440.52M | Sep 2008 |
| Average | -529.62M |
